Molecular and biochemical basis for the platelet dysfunction in myeloproliferative disorders

被引:6
作者
Rao, AK [1 ]
机构
[1] Temple Univ, Sch Med, Philadelphia, PA 19140 USA
关键词
D O I
10.1053/j.seminhematol.2004.02.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A large number of platelet abnormalities have been described in patients with myeloprolIferative disorders (MPDs). Platelet abnormalities include defects in receptor expression on the platelet surface, platelet-platelet interactions, and platelet activation mechanisms. These platelet defects are demonstrable even in patients who are asymptomatic. Both hemorrhagic and thrombotic events occur in MPD patients. The mechanisms that underlie the platelet dysfunction in patients with MPDs are examined. © 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
[41]   The molecular basis of platelet biogenesis, activation, aggregation and implications in neurological disorders [J].
Ludhiadch, Abhilash ;
Muralidharan, Abhishek ;
Balyan, Renuka ;
Munshi, Anjana .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2020, 130 (12) :1237-1249
[42]   FATAL MYELOPROLIFERATIVE SYNDROME IN A FAMILY WITH THROMBOCYTOPENIA AND PLATELET DYSFUNCTION [J].
LUDDY, RE ;
CHAMPION, LAA ;
SCHWARTZ, AD .
CANCER, 1978, 41 (05) :1959-1963
[43]   PLATELET AGGREGATION AND PLATELET FACTOR-3 ACTIVITY IN MYELOPROLIFERATIVE DISORDERS [J].
TANGUN, Y .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1971, 25 (02) :241-&
[44]   ABNORMAL PLATELET SUBPOPULATIONS IN MYELOPROLIFERATIVE DISORDERS IN RELATION TO PLATELET-FUNCTION [J].
WEHMEIER, A ;
SCHARF, RE ;
SCHNEIDER, W .
CELLULAR BLOOD COMPONENTS IN HAEMOSTASIS AND THROMBOSIS: IMPLICATIONS FROM MYELOPROLIFERATIVE DISORDERS, 1988, 1 :117-121
[45]   BIOCHEMICAL BASIS OF HEMOSTATIC DISORDERS [J].
MACHOVICH, R .
ACTA BIOCHIMICA ET BIOPHYSICA HUNGARICA, 1982, 17 (1-2) :58-58
[46]   Molecular genetics and cytogenetics of myeloproliferative disorders [J].
Bench, AJ ;
Nacheva, EP ;
Champion, KM ;
Green, AR .
BAILLIERES CLINICAL HAEMATOLOGY, 1998, 11 (04) :819-848
[47]   Molecular Defects in Chronic Myeloproliferative Disorders [J].
Maher Albitar ;
Emil J. Freireich .
Molecular Medicine, 2000, 6 :555-567
[48]   Molecular defects in chronic myeloproliferative disorders [J].
Albitar, M ;
Freireich, EJ .
MOLECULAR MEDICINE, 2000, 6 (07) :555-567
[49]   PLATELET THROMBOXANE SYNTHESIS AND RELEASE REACTIONS IN MYELOPROLIFERATIVE DISORDERS [J].
SMITH, IL ;
MARTIN, TJ .
HAEMOSTASIS, 1982, 11 (02) :119-127
[50]   A REVERSIBLE DEFECT OF PLATELET PDGF CONTENT IN MYELOPROLIFERATIVE DISORDERS [J].
BAGLIN, TP ;
PRICE, SM ;
BOUGHTON, BJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (01) :145-145